Na,K-ATPase isozymes in colorectal cancer and liver metastases

Citations of this article
Mendeley users who have this article in their library.


© 2016 Baker Bechmann, Rotoli, Morales, Maeso, García, Ávila, Mobasheri and Martín-Vasallo. The goal of this study was to define Na,K-ATPase α and β subunit isoform expression and isozyme composition in colorectal cancer cells and liver metastases. The α1, α3, and β1 isoforms were the most highly expressed in tumor cells and metastases; in the plasma membrane of non-neoplastic cells and mainly in a cytoplasmic location in tumor cells. α1β1 and α3β1 isozymes found in tumor and metastatic cells exhibit the highest and lowest Na + affinity respectively and the highest K + affinity. Mesenchymal cell isozymes possess an intermediate Na + affinity and a low K + affinity. In cancer, these ions are likely to favor optimal conditions for the function of nuclear enzymes involved in mitosis, especially a high intra-nuclear K + concentration. A major and striking finding of this study was that in liver, metastasized CRC cells express the α3β1 isozyme. Thus, the α3β1 isozyme could potentially serve as a novel exploratory biomarker of CRC metastatic cells in liver.




Bechmann, M. B., Rotoli, D., Morales, M., Maeso, M. del C., García, M. del P., Ávila, J., … Martín-Vasallo, P. (2016). Na,K-ATPase isozymes in colorectal cancer and liver metastases. Frontiers in Physiology, 7(JAN).

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free